Consumo de cannabis y alteraciones cognitivas en esquizofrenia y primeros episodios psicóticos

Autores/as

  • Leticia García Álvarez ISPA. Universidad de Oviedo. CIBERSAM. INEUROPA.
  • Jesus J. Gomar CIBERSAM. The Feinstein Institute for Medical Research. FIDMAG Hermanas Hospitalarias Research Foundation.
  • Mª Paz García-Portilla ISPA. Universidad de Oviedo. CIBERSAM. SESPA.
  • Julio Bobes ISPA. Universidad de Oviedo. CIBERSAM. SESPA.

DOI:

https://doi.org/10.20882/adicciones.1328

Palabras clave:

editorial

Resumen

Editorial del vol. 31, nº 2.

Biografía del autor/a

Leticia García Álvarez, ISPA. Universidad de Oviedo. CIBERSAM. INEUROPA.

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), EspañaÁrea de Psiquiatría. Universidad de Oviedo, EspañaCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), EspañaInstituto de Neurociencias del Principado de Asturias (INEUROPA), España Departamento de Psicología. Universidad de Oviedo,  España

Jesus J. Gomar, CIBERSAM. The Feinstein Institute for Medical Research. FIDMAG Hermanas Hospitalarias Research Foundation.

Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), EspañaThe Litwin-Zucker Research Center, The Feinstein Institute for Medical Research, Nueva York, NY, Estados UnidosFIDMAG Hermanas Hospitalarias Research Foundation & CIBERSAM, Sant Boi de Llobregat, España

Mª Paz García-Portilla, ISPA. Universidad de Oviedo. CIBERSAM. SESPA.

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), EspañaÁrea de Psiquiatría. Universidad de Oviedo, EspañaCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), EspañaDepartamento de Psicología. Universidad de Oviedo,  EspañaServicio de Salud del Principado de Asturias. SESPA, España

Julio Bobes, ISPA. Universidad de Oviedo. CIBERSAM. SESPA.

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), EspañaÁrea de Psiquiatría. Universidad de Oviedo, EspañaCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), EspañaDepartamento de Psicología. Universidad de Oviedo,  EspañaServicio de Salud del Principado de Asturias. SESPA, España

Citas

Asarnow, R. F., Nuechterlein, K. H., Subotnik, K. L., Fogelson, D. L., Torquato, R. D., Payne, D. L., . . . Guthrie, D. (2002). Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attentiondeficit/ hyperactivity disorder: the University of California, Los Angeles Family Study. Archives of General Psychiatry, 59, 1053-1060. doi:10.1001/archpsyc.59.11.1053.

Bahorik, A. L., Cornelius, J. R., Bangalore, S. S., Newhill, C. E., Keshavan, M. S. y Eack, S. M. (2014). Brief Report: The Impact of Alcohol and Cannabis Misuse on Cognition among Individuals with Schizophrenia. Schizophrenia Research: Cognition, 1, 160-163. doi:10.1016/j.scog.2014.08.001.

Barnes, T. R., Mutsatsa, S. H., Hutton, S. B., Watt, H. C. y Joyce, E. M. (2006). Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry, 188, 237-242. doi:10.1192/bjp.bp.104.007237.

Block, R. I., O’Leary, D. S., Ehrhardt, J. C., Augustinack, J. C., Ghoneim, M. M., Arndt, S. y Hall, J. A. (2000). Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport, 11, 491-496. doi:10.1097/00001756-200002280-00013.

Bugra, H., Studerus, E., Rapp, C., Tamagni, C., Aston, J., Borgwardt, S. y Riecher-Rossler, A. (2013). Cannabis use and cognitive functions in at-risk mental state and first episode psychosis. Psychopharmacology (Berl), 230, 299-308. doi:10.1007/s00213-013-3157-y.

Casajuana Kögel, C., López-Pelayo, H., Balcells-Olivero, M.M., Colom. J. y Gual A. (2018).  Psychoactive constituents of cannabis and their clinical implications: a systematic review. Adicciones, 30, 140-151. doi:10.20882/adicciones.858. 

Cunha, P. J., Rosa, P. G., Ayres Ade, M., Duran, F. L., Santos, L. C., Scazufca, M., . . . Schaufelberger, M. S. (2013). Cannabis use, cognition and brain structure in first-episode psychosis. Schizophrenia Research, 147, 209-215. doi:10.1016/j.schres.2013.04.009.

de la Serna, E., Mayoral, M., Baeza, I., Arango, C., Andres, P., Bombin, I., . . . Castro-Fornieles, J. (2010). Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers. The Journal of Nervous and Mental Disease, 198, 159-162. doi:10.1097/NMD.0b013e3181cc0d41.

DeRosse, P., Kaplan, A., Burdick, K. E., Lencz, T. y Malhotra, A. K. (2010). Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophrenia Research, 120, 95-100. doi:10.1016/j.schres.2010.04.007.

Elvevag, B. y Goldberg, T. E. (2000). Cognitive impairment in schizophrenia is the core of the disorder. Critical ReviewsTM in Neurobiology, 14, 1-21. doi:10.1615/CritRevNeurobiol.v14.i1.10.

Gage, S.H., Hickman, M. y Zammit, S. (2016). Association Between Cannabis and Psychosis: Epidemiologic Evidence. Biological Psychiatry, 79, 549-556. doi:10.1016/j.biopsych.2015.08.001.

Gonzalez-Pinto, A., Gonzalez-Ortega, I., Alberich, S., Ruiz de Azua, S., Bernardo, M., Bioque, M., . . . PEPs Group. (2016). Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History. Public Library of Science One, 11, e0160949. doi:10.1371/journal.pone.0160949.

Green, M. F., Kern, R. S. y Heaton, R. K. (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research, 72, 41-51. doi:10.1016/j.schres.2004.09.009.

Hanna, R. C., Shalvoy, A., Cullum, C. M., Ivleva, E. I., Keshavan, M., Pearlson, G., . . . Ghose, S. (2016). Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. Schizophrenia Bulletin, 42, 1496-1503. doi:10.1093/schbul/sbw030.

Heaton, R. K., Gladsjo, J. A., Palmer, B. W., Kuck, J., Marcotte, T. D. y Jeste, D. V. (2001). Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry, 58, 24-32. doi:10.1001/archpsyc.58.1.24.

Helle, S., Loberg, E. M., Gjestad, R., Schnakenberg Martin, A. M. y Lysaker, P. H. (2017). The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition. Psychiatry Research, 250, 92-98. doi:10.1016/j.psychres.2017.01.047.

Jager, G., Van Hell, H. H., De Win, M. M., Kahn, R. S., Van Den Brink, W., Van Ree, J. M. y Ramsey, N. F. (2007). Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology, 17, 289-297. doi:10.1016/j.euroneuro.2006.10.003.

Kern, R. S., Nuechterlein, K. H., Green, M. F., Baade, L. E., Fenton, W. S., Gold, J. M., . . . Marder, S. R. (2008). The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. The American Journal of Psychiatry, 165, 214-220. doi:10.1176/appi.ajp.2007.07010043.

Koskinen, J., Lohonen, J., Koponen, H., Isohanni, M. y Miettunen, J. (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin, 36, 1115-1130. doi:10.1093/schbul/sbp031.

Leeson, V. C., Harrison, I., Ron, M. A., Barnes, T. R. y Joyce, E. M. (2012). The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophrenia Bulletin, 38, 873-880. doi:10.1093/schbul/sbq153.

López Pelayo, H., de Miquel Montagut, L., Casajuana Kögel, C. y Balcells Oliveró, M. (2018). Post-truth Cannabis use: back to evidence-based medicine. Adicciones, 30, 237-242. doi:10.20882/adicciones.

Mallet, J., Ramoz, N., Le Strat, Y., Gorwood, P. y Dubertret, C. (2017). Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? European Archives of Psychiatry and Clinical Neuroscience, 267, 629-638. doi:10.1007/s00406-017-0767-0.

Martin-Santos, R., Fagundo, A. B., Crippa, J. A., Atakan, Z., Bhattacharyya, S., Allen, P., . . . McGuire, P. (2010). Neuroimaging in cannabis use: a systematic review of the literature. Psychological Medicine, 40, 383-398. doi:10.1017/S0033291709990729.

Meijer, J. H., Dekker, N., Koeter, M. W., Quee, P. J., van Beveren, N. J., Meijer, C. J., . . . Outcome of Psychosis, Investigators. (2012). Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Psychological Medicine, 42, 705-716. doi:10.1017/S0033291711001656.

Menendez-Miranda, I., García-Alvarez, L., García-Portilla, P., Gonzalez-Blanco, L., Saiz, P. y Bobes, J. (2019). History of lifetime cannabis use is associated with better cognition and worse real-world functioning in schizophrenia spectrum disorders. European Addiction Research, 25, 111-118. doi:10.1159/000497317. 

Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M. y Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370, 319-328. doi:10.1016/S0140-6736(07)61162-3.

Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., . . . Marder, S. R. (2008). The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. The American Journal of Psychiatry, 165, 203-213. doi:10.1176/appi.ajp.2007.07010042.

Nunez, C., Ochoa, S., Huerta-Ramos, E., Banos, I., Barajas, A., Dolz, M., . . . Usall, J. (2016). Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. Psychopharmacology (Berl), 233, 809-821. doi:10.1007/s00213-015-4160-2.

Potvin, S., Stavro, K. y Pelletier, J. (2012). Paradoxical cognitive capacities in dual diagnosis schizophrenia: the quest for explanatory factors. Journal of Dual Diagnosis, 8, 35–47. doi:10.1080/15504263.2012.648549.

Power, B. D., Dragovic, M., Badcock, J. C., Morgan, V. A., Castle, D., Jablensky, A. y Stefanis, N. C. (2015). No additive effect of cannabis on cognition in schizophrenia. Schizophrenia Research, 168, 245-251. doi:10.1016/j.schres.2015.06.026.

Rabin, R. A., Barr, M. S., Goodman, M. S., Herman, Y., Zakzanis, K. K., Kish, S. J., . . . George, T. P. (2017). Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls. Neuropsychopharmacology, 42, 2259-2271. doi:10.1038/npp.2017.85.

Rabin, R. A., Zakzanis, K. K., Daskalakis, Z. J. y George, T. P. (2013). Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry Research, 206, 158-165. doi:10.1016/j.psychres.2012.11.019.

Ringen, P. A., Nesvag, R., Helle, S., Lagerberg, T. V., Lange, E. H., Loberg, E. M., . . . Melle, I. (2016). Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder. Psychological Medicine, 46, 3127-3136. doi:10.1017/S0033291716001999.

Rodriguez-Sanchez, J. M., Ayesa-Arriola, R., Mata, I., Moreno-Calle, T., Perez-Iglesias, R., Gonzalez-Blanch, C., . . . Crespo-Facorro, B. (2010). Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophrenia Research, 124, 142-151. doi:10.1016/j.schres.2010.08.017.

Sanchez-Torres, A. M., Basterra, V., Rosa, A., Fananas, L., Zarzuela, A., Ibanez, B., . . . Cuesta, M. J. (2013). Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings. European Archives of Psychiatry and Clinical Neuroscience, 263, 643-653. doi:10.1007/s00406-013-0404-5.

Schimmelmann, B.G., Conus, P., Cotton, S., Kupferschmid, S., McGorry, P.D. y Lambert, M. (2012). Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. European Psychiatry, 27, 463–469. doi:10.1016/j.eurpsy.2011.03.001.

Schnakenberg Martin, A.M., Bonfils, K.A., Davis, B.J., Smith, E.A., Schuder, K. y Lysaker, P.H. (2016). Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis. Schizophrenia Research: Cognition, 6, 15-21. doi:10.1016/j.scog.2016.09.001.

Schnell, T., Koethe, D., Daumann, J. y Gouzoulis-Mayfrank, E. (2009). The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (Berl), 205, 45-52. doi:10.1007/s00213-009-1512-9.

Setien-Suero, E., Martinez-Garcia, O., de la Foz, V. O., Vazquez-Bourgon, J., Correa-Ghisays, P., Ferro, A., . . . Ayesa-Arriola, R. (2018). Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up. Schizophrenia Research, 201, 159-166. doi:10.1016/j.schres.2018.05.036.

van Os, J., Bak, M., Hanssen, M., Bijl, R. V., de Graaf, R. y Verdoux, H. (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology, 156, 319-327. doi:10.1093/aje/kwf043. 

Waterreus, A., Badcock, J. C., Di Prinzio, P., Martin-Iverson, M. y Morgan, V. A. (2017). The impact of current cannabis use on general cognitive function in people with psychotic illness. Schizophrenia Research, 190, 164-171. doi:10.1016/j.schres.2017.03.038.

Yucel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., . . . Pantelis, C. (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin, 38, 316-330. doi:10.1093/schbul/sbq079.

Descargas

Publicado

2019-04-01

Número

Vol. 31 Núm. 2 (2019)

Sección

Editorial